Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,257,799 papers from all fields of science
Search
Sign In
Create Free Account
desmethylselegiline
Known as:
demethyl-deprenyl-DMD
, di-N-propargylamphetamine
, N-desmethyl-selegiline
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Amphetamines
Monoamine Oxidase Inhibitors
Narrower (1)
desmethylselegiline, (-)-isomer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Differential effects of selegiline on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies.
J. Drożak
,
M. Kozłowski
,
+4 authors
J. Bryła
Chemico-Biological Interactions
2007
Corpus ID: 21289822
2003
2003
Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
L. Dirikolu
,
A. Lehner
,
+6 authors
T. Tobin
Veterinary therapeutics : research in applied…
2003
Corpus ID: 25892935
Selegiline ([R]-[-]N,alpha-dimethyl-N-2- propynylphenethylamine or l-deprenyl), an irreversible inhibitor of monoamine oxidase…
Expand
2001
2001
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole
K. Kivistö
,
Jun-sheng Wang
,
+4 authors
P. Neuvonen
European Journal of Clinical Pharmacology
2001
Corpus ID: 12495353
Abstract. Objective: To characterise the effects of itraconazole, a potent inhibitor of CYP3A4, on the pharmacokinetics of…
Expand
2001
2001
Cytochrome P450 isoform-specific in vitro methods to predict drug metabolism and interactions
P. Taavitsainen
2001
Corpus ID: 53073011
Cytochromes P450 (P450, CYP) are a superfamily of enzymes that participate especially in the oxidative metabolism of various…
Expand
2001
2001
CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline
K. Laine
,
M. Anttila
,
L. Nyman
,
A. Wahlberg
,
L. Bertilsson
European Journal of Clinical Pharmacology
2001
Corpus ID: 13191324
Abstract. Objectives: To address the relevance of cytochrome P-450 (CYP) 2C19 polymorphism for the pharmacokinetics and dynamics…
Expand
2000
2000
Determination of enantiomeric metabolites of l-deprenyl, d-methamphetamine, and racemic methamphetamine in urine by capillary electrophoresis: comparison of deprenyl use and methamphetamine use.
E. Kim
,
H. Chung
,
Kwan Jun Lee
,
H. J. Kim
Journal of Analytical Toxicology
2000
Corpus ID: 12672243
The enantiomeric analysis of urine collected from rats administered l-deprenyl, d-methamphetamine (MA), or dl-MA and from healthy…
Expand
1999
1999
Biotransformation of deprenyl enantiomers
É. Szökő
,
H. Kalasz
,
K. Magyar
European journal of drug metabolism and…
1999
Corpus ID: 29230433
SummaryRats were treated with either (−)- or (+)-deprenyl, and the metabolites extracted from the plasma, liver, kidney and heart…
Expand
1998
1998
CYP2D6 polymorphism is not crucial for the disposition of selegiline
Harry Scheinin
,
M. Anttila
,
+5 authors
L. Bertilsson
Clinical pharmacology and therapy
1998
Corpus ID: 40838249
1996
1996
Absorption and Presystemic Metabolism of Selegiline Hydrochloride at Different Regions in the Gastrointestinal Tract in Healthy Males
J. Barrett
,
P. Szego
,
+4 authors
Joyce Ireland
Pharmaceutical Research
1996
Corpus ID: 24654277
AbstractPurpose. The absorption and disposition of selegiline (SEL) and its metabolites N-desmethylselegiline (DMS), L…
Expand
1996
1996
Bioavailability of two selegiline hydrochloride tablet products.
F. Müller
,
R. Schall
,
+6 authors
K. Swart
Arzneimittel-Forschung
1996
Corpus ID: 529181
The bioavailability of two selegiline HCl (CAS 14611-52-0) tablet products was compared in a single-blind, single-dose…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE